Actinium Pharmaceuticals, Inc.
At Close: 4:00 PM
ATNM Stock Price Graph
ATNM Stock Price Today
Actinium Pharmaceuticals, Inc. (ATNM) stock rallied over 0.38% intraday to trade at $5.32 a share on AMEX. The stock opened with a gain of 4.34% at $5.53 and touched an intraday high of $5.60, rising 0.38% against the last close of $5.30. The Actinium Pharmaceuticals, Inc. in stock market went to a low of $5.32 during the session.
ATNM Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
ATNM Stock Price History Chart
Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly relapsed or refractory acute myeloid leukemia trial for BMT conditioning; and a Phase I study with a CD19- targeted CAR T-cell therapy with memorial sloan kettering cancer center. The company also offers clinical and preclinical development programs that utilize multiple isotopes, including Actinium-225, Iodine-131, and Lutetium-177 directed at multiple validated cancer targets, including CD45, CD33, CD38, CD47, HER2, and HER3 for targeted conditioning prior to cell and gene therapies, such as bone marrow transplant and cancer therapeutics as single agents or in combination with other therapeutic modalities. It has collaboration with Astellas Pharma, Inc. to develop theranostics for solid tumor indications; EpicentRx, Inc that focuses on a novel CD47 immunotherapy targeted radiotherapy; and AVEO Oncology that focuses on developing a HER3 targeting ARC for solid tumors. The company was incorporated in 2000 and is based in New York, New York.
Frequently Asked Questions
What is the current Actinium Pharmaceuticals, Inc. (ATNM) stock price?
Actinium Pharmaceuticals, Inc. (AMEX: ATNM) stock price is $5.32 in the last trading session. During the trading session, ATNM stock reached the peak price of $5.60 while $5.32 was the lowest point it dropped to. The percentage change in ATNM stock occurred in the recent session was 0.38% while the dollar amount for the price change in ATNM stock was $0.02.
ATNM's industry and sector of operation?
The AMEX listed ATNM is part of Biotechnology industry that operates in the broader Healthcare sector. Actinium Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies.
Who are the executives of ATNM?
Dr. Qing Liang
Vice President & Head of Radiation Sciences
Dr. David Gould
Senior Vice President of Corporation Devel. & Corp. Affairs
Mr. Steven O'Loughlin BS
Chief Financial Officer & Corporation Sec.
Dr. Mamata Gokhale
Vice President & Global Head of Regulatory Affairs
How ATNM did perform over past 52-week?
ATNM's closing price is 0.89% higher than its 52-week low of $5.32 where as its distance from 52-week high of $15.12 is -0.42%.
How many employees does ATNM have?
Number of ATNM employees currently stands at 49.00. ATNM operates from 275 Madison Avenue, New York, NY 10016, US.
Link for ATNM official website?
Official Website of ATNM is: https://www.actiniumpharma.com
How do I contact ATNM?
How many shares of ATNM are traded daily?
ATNM stock volume for the day was 101855.00 shares. The average number of ATNM shares traded daily for last 3 months was 194.16 Thousands.
What is the market cap of ATNM currently?
The market value of ATNM currently stands at $145.82 Million with its latest stock price at $5.32 and 27.41 Million of its shares outstanding.